title: Low-level laser therapy improves crescentic glomerulonephritis in rats.
abstract: Low-level laser therapy (LLLT) can reduce inflammation in a variety of clinical conditions, including trauma, postherpetic neuralgia, and rheumatoid arthritis. However, the effect of LLLT on internal organs has not been elucidated. The goal of the present study was to investigate the anti-inflammatory effect of daily external LLLT in an animal model of crescentic glomerulonephritis. Crescentic glomerulonephritis was induced in male Wister Kyoto rats by intravenous injection of antibody for glomerular basement membrane (GBM). The rats were irradiated with a low-reactive level diode laser with an infrared wavelength of 830 nm from the shaved skin surface once a day for 14 days (irradiation spot size on the skin surface, 2.27 cm(2); power intensity, 880 mW/cm(2); irradiation mode, continuous mode; irradiation time, 250 s; energy, 500 J; energy density, 220 J/cm(2)). After laser irradiation for 14 days, animals were killed, and the extent of inflammation was evaluated. Expression of gene for inflammatory cytokines including interleukin (IL)-1β and tumor necrosis factor alpha (TNF-α) was assessed by reverse transcription polymerase chain reaction. Crescent formation in glomeruli and infiltration of macrophages and lymphocytes were assessed by histochemical observation. Injection of anti-GBM antibody induced severe glomerulonephritis with crescent formation. Histological observations indicated that LLLT suppressed crescent formation and infiltration of ED1+ macrophages and CD8+ lymphocytes into the glomeruli. LLLT attenuated the levels of IL-1β and TNF-α messenger RNA in the renal cortex. Externally directed LLLT suppresses the activity of rat anti-GBM crescentic glomerulonephritis in rats. LLLT has the potential to be used for direct treatment of glomerulonephritis.
authors.affiliation: Cellular Function Imaging Laboratory, RIKEN Center for Molecular Imaging Science, 6-7-3 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
authors.forename: Masanori
authors.initials: M
authors.lastname: Yamato
authors.forename: Akira
authors.initials: A
authors.lastname: Kaneda
authors.forename: Yosky
authors.initials: Y
authors.lastname: Kataoka
mesh_terms: D000818:Animals; D019867:Anti-Glomerular Basement Membrane Disease / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy; D001323:Autoantibodies / Q000008:administration & dosage; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000528:radiation effects; D016207:Cytokines / Q000096:biosynthesis; D004195:Disease Models, Animal; D050533:Glomerular Basement Membrane / Q000276:immunology; D005921:Glomerulonephritis / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy*; D018836:Inflammation Mediators / Q000378:metabolism; D028022:Low-Level Light Therapy / Q000379:methods*; D008264:Macrophages / Q000276:immunology / Q000528:radiation effects; D008297:Male; D051381:Rats; D011921:Rats, Inbred WKY
chemical_list: D001323:Autoantibodies; D016207:Cytokines; D018836:Inflammation Mediators; C051951:antiglomerular basement membrane antibody